SCHEMBL2904782

SCHEMBL2904782

Cc1cc(C#N)cc2c(=O)oc(=O)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
F2 P00734 1/20 0.34
CFD P00746 1/20 0.34
GRM5 P41594 1/20 0.34
HSD17B3 P37058 1/20 0.33
UPP1 Q16831 1/20 0.32
KDM4E B2RXH2 1/20 0.32
RECQL P46063 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
JAK1 P23458 2/20 0.32
JAK3 P52333 2/20 0.32
CSF1R P07333 1/20 0.32
MAOB P27338 2/20 0.32
MAOA P21397 1/20 0.32
PDGFRA P16234 1/20 0.31
MAPK8 P45983 1/20 0.31
CDK5 Q00535 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14698490 0.81 FASN (0.47) NOS3NOS1NOS2F2CFD
SCHEMBL14698412 0.81 CTDSP1 (0.37) NOS3NOS1NOS2F2CFD
SCHEMBL5280067 0.78 ABCB1 (0.46) NOS3NOS1NOS2F2CFD
SCHEMBL30087001 0.76 LMNA (0.38) NOS3NOS1NOS2F2CFD
SCHEMBL13208799 0.76 F2 (0.37) NOS3NOS1NOS2F2CFD
SCHEMBL3208633 0.76 GSK3B (0.38) NOS3NOS1NOS2F2CFD
SCHEMBL2906293 0.76 F2 (0.37) NOS3NOS1NOS2F2CFD
SCHEMBL14698434 0.76 F2 (0.37) NOS3NOS1NOS2F2CFD
SCHEMBL634152 0.76 LMNA (0.38) NOS3NOS1NOS2F2CFD
SCHEMBL17303417 0.72 MAOA (0.36) F2CFDMAOBMAOAPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112920277-B VHH-ELISA kit for analyzing cyantraniliprole and chlorantraniliprole residues and application thereof 中国农业大学 2022-08-09 CN claimed
CN-120379959-A Process for preparing cyantraniliprole via amino-cyano-benzene derivatives 安道麦马克西姆有限公司 2025-07-25 CN disclosed
WO-2024038436-A1 PROCESS FOR PREPARING CYANTRANILIPROLE VIA AMINO-CYANO-BENZENE DERIVATIVE ADAMA MAKHTESHIM LTD. (IL) 2024-02-22 WO disclosed
WO-2024038436-A1 PROCESS FOR PREPARING CYANTRANILIPROLE VIA AMINO-CYANO-BENZENE DERIVATIVE ADAMA MAKHTESHIM LTD. (IL) 2024-02-22 WO disclosed
US-20230339844-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI INDUSTRIES LTD. (IN) 2023-10-26 US disclosed
EP-4214188-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI Industries Ltd. (IN) 2023-07-26 EP disclosed
CN-112920277-B VHH-ELISA kit for analyzing cyantraniliprole and chlorantraniliprole residues and application thereof 中国农业大学 2022-08-09 CN disclosed
WO-2022058916-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI INDUSTRIES LIMITED (IN) 2022-03-24 WO disclosed
CN-112920277-A VHH-ELISA kit for analyzing cyantraniliprole and chlorantraniliprole residues and application thereof 中国农业大学 2021-06-08 CN disclosed
US-9556141-B2 Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof BASF SE (DE) 2017-01-31 US disclosed
US-20080182750-A1 Cyano Anthranilamide Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2008-07-31 US disclosed
US-20080182750-A1 Cyano Anthranilamide Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2008-07-31 US disclosed
EP-1871760-A1 CYANO ANTHRANILAMIDE INSECTICIDES Syngeta Participations AG (CH) 2008-01-02 EP disclosed
US-7276601-B2 Method and preparing fused oxazinones E.I. DU PONT DE NEMOURS AND COMPANY (US) 2007-10-02 US disclosed
EP-1771070-A1 MIXTURES OF ANTHRANILAMIDE INVERTEBRATE PEST CONTROL AGENTS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-04-11 EP disclosed
US-20060241304-A1 Method for preparing fused oxazinones FMC CORPORATION 2006-10-26 US disclosed
WO-2006111341-A1 CYANO ANTHRANILAMIDE INSECTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2006-10-26 WO disclosed
WO-2006068669-A1 MIXTURES OF ANTHRANILAMIDE INVERTEBRATE PEST CONTROL AGENTS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-06-29 WO disclosed
EP-1631564-A1 METHOD FOR PREPARING FUSED OXAZINONES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-03-08 EP disclosed
WO-2004111030-A1 METHOD FOR PREPARING FUSED OXAZINONES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339844-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF ASS1, ACMSD, ADCY10 NOS3 276/4885NOS1 284/4885NOS2 161/4885
US-20080182750-A1 Cyano Anthranilamide Insecticides CRY1, CRYAA, ALDH7A1 NOS3 1590/4885NOS1 460/4885NOS2 1045/4885
US-20060241304-A1 Method for preparing fused oxazinones STS, CA5A, SQOR NOS3 1828/4885NOS1 1347/4885NOS2 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.